168 related articles for article (PubMed ID: 36233826)
1. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.
Trifan A; Stafie R; Rotaru A; Stratina E; Zenovia S; Nastasa R; Huiban L; Cuciureanu T; Muzica C; Chiriac S; Girleanu I; Singeap AM; Sfarti C; Cojocariu C; Petrea O; Stanciu C
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233826
[TBL] [Abstract][Full Text] [Related]
2. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter.
Trifan A; Stratina E; Nastasa R; Rotaru A; Stafie R; Zenovia S; Huiban L; Sfarti C; Cojocariu C; Cuciureanu T; Muzica C; Chiriac S; Girleanu I; Singeap AM; Stanciu C
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885657
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease.
Veltkamp C; Lan S; Korompoki E; Weiss KH; Schmidt H; Seitz HK
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566749
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
Yen HH; Su PY; Huang SP; Wu L; Hsu TC; Zeng YH; Chen YY
PLoS One; 2021; 16(5):e0252286. PubMed ID: 34043691
[TBL] [Abstract][Full Text] [Related]
5. Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Zenovia S; Stanciu C; Sfarti C; Singeap AM; Cojocariu C; Girleanu I; Dimache M; Chiriac S; Muzica CM; Nastasa R; Huiban L; Cuciureanu T; Trifan A
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925569
[TBL] [Abstract][Full Text] [Related]
6. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.
Sporea I; Mare R; Popescu A; Nistorescu S; Baldea V; Sirli R; Braha A; Sima A; Timar R; Lupusoru R
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268517
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
[TBL] [Abstract][Full Text] [Related]
8. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G
Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.
Nastasa R; Stanciu C; Zenovia S; Singeap AM; Cojocariu C; Sfarti C; Girleanu I; Chiriac S; Cuciureanu T; Huiban L; Muzica CM; Trifan A
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943578
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
[TBL] [Abstract][Full Text] [Related]
11. Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease.
Shalimar ; Kumar R; Rout G; Kumar R; Yadav R; Das P; Aggarwal S; Gunjan D; Saraya A; Nayak B
Indian J Gastroenterol; 2020 Feb; 39(1):32-41. PubMed ID: 32185692
[TBL] [Abstract][Full Text] [Related]
12. Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up.
van Lingen E; Tushuizen ME; Steenhuis MEJ; van Deynen T; Martens J; Morales DD; van der Meulen-de Jong AE; Molendijk I; van der Marel S; Maljaars PWJ
Int J Colorectal Dis; 2022 Feb; 37(2):349-356. PubMed ID: 34791524
[TBL] [Abstract][Full Text] [Related]
13. Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis.
Cuomo G; Iandoli C; Galiero R; Caturano A; Di Vico C; Perretta D; Adamo PV; Ferrara R; Rinaldi L; Romano C; Sasso FC
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238250
[No Abstract] [Full Text] [Related]
14. Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography.
Teeratorn N; Piyachaturawat P; Thanapirom K; Chaiteerakij R; Sonsiri K; Komolmit P; Tangkijvanich P; Rerknimitr R; Adams L; Treeprasertsuk S
JGH Open; 2020 Apr; 4(2):245-250. PubMed ID: 32280772
[TBL] [Abstract][Full Text] [Related]
15. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
16. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.
Rout G; Nayak B; Patel AH; Gunjan D; Singh V; Kedia S; Shalimar
J Clin Exp Hepatol; 2019; 9(2):207-214. PubMed ID: 31024203
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan
Oeda S; Takahashi H; Imajo K; Seko Y; Ogawa Y; Moriguchi M; Yoneda M; Anzai K; Aishima S; Kage M; Itoh Y; Nakajima A; Eguchi Y
J Gastroenterol; 2020 Apr; 55(4):428-440. PubMed ID: 31654131
[TBL] [Abstract][Full Text] [Related]
19. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases.
Kablawi D; Aljohani F; Palumbo CS; Restellini S; Bitton A; Wild G; Afif W; Lakatos PL; Bessissow T; Sebastiani G
Crohns Colitis 360; 2023 Jan; 5(1):otad004. PubMed ID: 36846097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
